BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4251631)

  • 1. Human serum plasminogen antiactivator: its distinction from antiplasmin.
    Aoki N; Von Kaulla KN
    Am J Physiol; 1971 Apr; 220(4):1137-45. PubMed ID: 4251631
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen.
    Wallén P; Wiman B
    Biochim Biophys Acta; 1972 Jan; 257(1):122-34. PubMed ID: 4257942
    [No Abstract]   [Full Text] [Related]  

  • 3. The isolation and characterisation of a platelet-specific beta-globulin (beta-thromboglobulin) and the detection of antiurokinase and antiplasmin released from thrombin-aggregated washed human platelets.
    Moore S; Pepper DS; Cash JD
    Biochim Biophys Acta; 1975 Feb; 379(2):360-9. PubMed ID: 47244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of human serum plasminogen antiactivator by synthetic fibrinolysis inducers.
    Aoki N; von Kaulla KN
    Thromb Diath Haemorrh; 1969 Nov; 22(2):251-62. PubMed ID: 4985767
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunochemical distinction between antiplasmin and alpha-antitrypsin.
    Collen D; De Cock ; Verstraete M
    Thromb Res; 1975 Jul; 7(1):245-9. PubMed ID: 1080301
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.
    Falanga A; Gordon SG
    Biochemistry; 1985 Sep; 24(20):5558-67. PubMed ID: 3935163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet factor 4--antiheparin protein releasable from platelets. Purification and properties.
    Nath N; Niewiarowski S; Joist JH
    J Lab Clin Med; 1973 Nov; 82(5):754-68. PubMed ID: 4201037
    [No Abstract]   [Full Text] [Related]  

  • 8. Human sperm acrosomal proteinase: antibody inhibition and immunologic dissimilarity to human pancreatic trypsin.
    Zaneveld LJ; Schumacher GF; Travis J
    Fertil Steril; 1973 Jun; 24(6):479-84. PubMed ID: 4267894
    [No Abstract]   [Full Text] [Related]  

  • 9. Further studies of plasminogen proactivator.
    Takada A; Takada Y; Ambrus JL
    Biochim Biophys Acta; 1972 May; 263(3):610-8. PubMed ID: 4624542
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluorescence polarization assay of plasmin, plasminogen, and plasminogen activator.
    Kinoshita K; Maeda H; Hinuma Y
    Anal Biochem; 1980 May; 104(1):15-22. PubMed ID: 6446247
    [No Abstract]   [Full Text] [Related]  

  • 11. Distinction of serum inhibitor of activator-induced clot lysis from alpha1-antitrypsin.
    Aoki N; Moroi M
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):567-70. PubMed ID: 4275737
    [No Abstract]   [Full Text] [Related]  

  • 12. The separation of the substrates for plasma kallikrein and plasmin from a human kininogen.
    Mackay M; Combridge BS
    Br J Exp Pathol; 1970 Aug; 51(4):356-60. PubMed ID: 4098642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FURTHER STUDIES ON THE PURIFICATION AND CHARACTERIZATION OF HUMAN PLASMINOGEN AND PLASMIN.
    ROBBINS KC; SUMMARIA L; ELWYN D; BARLOW GH
    J Biol Chem; 1965 Jan; 240():541-50. PubMed ID: 14253466
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation and physicochemical and immunologic characterization of human platelet factor 3.
    Sharma NC; Mohammad SF; Chuang HY; Mason RG
    Thromb Res; 1979; 16(5-6):673-87. PubMed ID: 118541
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasminogen and antiplasmin activity in various disorders. Comparison between the method by affinity chromatography and that with euglobulin fraction (author's transl)].
    Matsumoto M
    Nihon Ketsueki Gakkai Zasshi; 1974 Dec; 37(6):834-42. PubMed ID: 4283387
    [No Abstract]   [Full Text] [Related]  

  • 16. The structure of the fibrinogen degradation products.
    Marder VJ; Budzynski AZ
    Prog Hemost Thromb; 1974; 2(0):141-74. PubMed ID: 4137300
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of proteolytic and fibrinolytic factors in the human prostate.
    Nijs M; Brassinne C; Coune A; Tagnon HJ
    Thromb Diath Haemorrh; 1971 Jun; 25(3):481-98. PubMed ID: 4104828
    [No Abstract]   [Full Text] [Related]  

  • 18. NH2-terminal sequences of mammalian plasminogens and plasmin S-carboxymethyl heavy (A) and light (B) chain derivatives. A re-evaluation of the mechanism of activation of plasminogen.
    Robbins KC; Bernabe P; Arzadon L; Summaria L
    J Biol Chem; 1973 Oct; 248(20):7242-6. PubMed ID: 4270330
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
    Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissimilarity of human vascular plasminogen activator and human urokinase.
    Aoki N; Von Kaulla KN
    J Lab Clin Med; 1971 Sep; 78(3):354-62. PubMed ID: 4106032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.